Author

Benjamin S. Beresford-Jones

University of CambridgeORCID 0000-0002-4699-8975Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metagenomics· 1

Frequent Co-Authors

Alberto G. ContiiD· 1 shared Alexander C. EvansiD· 1 shared Alexander J. WesolowskiiD· 1 shared Amelia T. SoderholmiD· 1 shared Charlotte J. ImianowskiiD· 1 shared Clare Elizabeth BryantiD· 1 shared Emily A. L. McCord· 1 shared Justin R. CrossiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Alberto G. ContiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Hexa-acylated lipopolysaccharides from the gut microbiota enhance cancer immunotherapy responses

Puspendu Sardar, Benjamin S. Beresford-Jones, Wangmingyu Xia, Omar Shabana, Satoshi Suyama, Ruben J. Jesus Faustino Ramos, Amelia T. Soderholm, Panagiotis Tourlomousis, Paula Kuo, Alexander C. Evans, Charlotte J. Imianowski, Alberto G. Conti, Alexander J. Wesolowski, Natalie M. Baker, Emily A. L. McCord, , Virginia Ahn Pedicord

The paper identifies hexa-acylated lipopolysaccharides from the gut microbiome as a biomarker and enhancer of anti-PD-1 immunotherapy responses in melanoma patients.

Nature Microbiology · Feb 10, 2025Peer-reviewedMicrobiology